glp-1 obesity drug news today oct 23 2025 Agonists Weight Loss Drugs Market Report, 2025-2030 GLP-1 Weight-Loss Drug Demonstration Begins

It is a subcutaneous injection given with a small needle, typically in the abdomen at home before bed, and the team walks you through the process and stays available for questions

In one study, people with obesity who received vitamin D supplements in addition to following a weight loss diet plan lost more weight and fat mass than the members of the placebo group, who only followed the diet plan

However, a 2020 review notes that more research is necessary to support the use of L-carnitine for better exercise performance

The STEP trials are testing semaglutide at the higher dose of 2.4 mg/week (as compared to 1.0 mg/week for the original diabetes indication), specifically for promoting weight loss, regardless of the presence of type 2 diabetes